Decoy Therapeutics is trading 5.04% down at $2.64 amid a broad risk-off session.

  • The Dow Jones Industrial Average is down 1.07%, while the S&P 500 is down 0.37%.
  • No clear company-specific negative catalyst was identified; a September 9–10 investor conference presentation does not directly explain the decline.
  • Trading activity is elevated during the open market session.